Displaying archives for 2017 September:

Addario Lung Cancer Medical Research Institute and Inivata Announce Major Study of ctDNA Analysis in Early Stage Lung Cancer

Posted by Bradley Newton on September 27th, 2017 |

InVision™ ctDNA liquid biopsy platform to be used to inform therapy following surgery of curative intent San Carlos, CA, Research Triangle Park, NC, and Cambridge, UK (September 27, 2017) — Addario Lung Cancer Medical Research Institute (ALCMI), a patient-founded not-for-profit global research consortium, and Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid… Read More